Differential counts and survival in lung cancer.
作者信息
Check I J, DeMeester T, Vardiman J, Hunter R L
出版信息
Lancet. 1978 Dec 16;2(8103):1317-8. doi: 10.1016/s0140-6736(78)92089-5.
PMID:82829
Abstract
摘要
相似文献
1
Differential counts and survival in lung cancer.
Lancet. 1978 Dec 16;2(8103):1317-8. doi: 10.1016/s0140-6736(78)92089-5.
2
Pretreatment peripheral blood counts in small-cell carcinoma of the lung.
JAMA. 1982 Aug 6;248(5):550.
3
Leucocyte-counts and survival in unresectable lung cancer.
Lancet. 1979 Feb 17;1(8112):383-4. doi: 10.1016/s0140-6736(79)92924-6.
4
Pretreatment serum albumin concentration and lactic dehydrogenase activity as prognostic factors in patients with small cell lung cancer.
Acta Med Okayama. 1982 Dec;36(6):487-90. doi: 10.18926/AMO/30668.
5
Plasma calcitonin in small cell lung cancer: prognostic significance.小细胞肺癌中的血浆降钙素：预后意义
Br J Cancer. 1983 Dec;48(6):881-2. doi: 10.1038/bjc.1983.283.
6
Thymosin immunotherapy in patients with small cell carcinoma of the lung: correlation of in vitro studies with clinical course.
Cancer. 1979 Mar;43(3):863-70. doi: 10.1002/1097-0142(197903)43:3<863::aid-cncr2820430313>3.0.co;2-5.
7
Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study.支气管癌患者的血沉、白细胞、血小板计数及血红蛋白：一项流行病学研究。
Eur J Respir Dis. 1985 Feb;66(2):141-6.
8
[Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].癌胚抗原（CEA）、组织多肽抗原（TPA）、烯醇化酶（NSE）和胸苷激酶（TK）在肺癌原发性监测及预后中的应用价值
J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):135-40.
9
[Is hyponatremia a prognostic marker of survival for lung cancer?].低钠血症是肺癌生存的预后标志物吗？
Pneumologie. 2011 Sep;65(9):565-71. doi: 10.1055/s-0030-1256668. Epub 2011 Aug 11.
10
[Correlation between the tumor marker Pro-GRP and prognosis in patients with small-cell lung cancer].[肿瘤标志物胃泌素释放肽前体（Pro-GRP）与小细胞肺癌患者预后的相关性]
Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Jun;35(6):616-21.
引用本文的文献
1
Assessing methods--transforming the data.评估方法——数据转换
Br Med J (Clin Res Ed). 1981 Aug 22;283(6290):548-50. doi: 10.1136/bmj.283.6290.548.
2
Leukocytosis in non hematological malignancies--a possible tumor-associated marker.非血液系统恶性肿瘤中的白细胞增多症——一种可能的肿瘤相关标志物。
J Cancer Res Clin Oncol. 1986;111(1):54-8. doi: 10.1007/BF00402777.
Zotero 插件